Related Experiment Video

Updated: May 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Lipids, blood pressure, kidney - what was new in 2011?

Marcin Barylski1, Jolanta Małyszko, Jacek Rysz

  • 1Department of Internal Diseases and Cardiological Rehabilitation, Medical University of Lodz, Poland.

Archives of Medical Science : AMS
|February 14, 2012
PubMed

Insights

2011 brought significant updates in lipidology, hypertensiology, and nephrology, including new European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) dyslipidemia guidelines and American College of Cardiology Foundation (ACCF)/American Heart Association (AHA) hypertension guidelines.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Lipidology
  • Hypertensiology

Background:

  • 2011 marked a pivotal year for advancements in cardiovascular and renal medicine.
  • Key developments included new clinical guidelines and trial results impacting patient care.

Purpose of the Study:

  • To summarize major developments in lipidology, hypertensiology, and nephrology from 2011.
  • To highlight significant new guidelines and trial findings presented at major medical congresses.

Main Methods:

  • Review of newly published guidelines from European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) and American College of Cardiology Foundation (ACCF)/American Heart Association (AHA).
  • Analysis of key clinical trials presented at the American Society of Nephrology (ASN) and American Heart Association (AHA) Annual Congresses.
  • Synthesis of information to provide a comprehensive overview of the year's progress.

Main Results:

  • Introduction of updated ESC/EAS guidelines for managing dyslipidemias.
  • Publication of ACCF/AHA guidelines focusing on hypertension management in the elderly population.
  • Presentation of numerous impactful trials at major nephrology and cardiology conferences.

Conclusions:

  • The year 2011 provided critical updates and new evidence-based recommendations in lipid management, hypertension, and nephrology.
  • These advancements are essential for clinicians to optimize patient care and outcomes in these fields.

Keywords:
anaemiablood pressuredyslipidaemiahypertensionlipidsrenal diseasetransplantation

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Blood Pressure01:30

Blood Pressure

Blood pressure (BP) is the pressure or force of blood exerted on the artery's walls as it circulates through the body. It is essential for maintaining blood flow throughout the body.
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the diastolic...